Ascrinvacumab

Tax included
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC).
MedChemExpress 
HY-P99353

Data sheet

Size
Multiple sizes
Reactivity
Anaplastic lymphoma kinase (ALK)
Application
Cancer-Kinase/protease
CAS
1463459-96-2